Warriors Grapple with Kristaps Porziņģis’ Mysterious Absence as Season Opener Looms

The Golden State Warriors are navigating a turbulent preseason, with just nine days separating them from their highly anticipated regular season opener against the Los Angeles Lakers on October 21st, according to a recent report by sportsamo.com. Central to their mounting anxieties is the continued absence of star big man Kristaps Porziņģis, whose availability remains shrouded in uncertainty following his offseason re-signing to a two-year, $40 million deal. The towering Latvian, intended to be a pivotal piece in the Warriors’ championship puzzle, has been sidelined indefinitely by a mysterious illness, casting a significant shadow over the team’s preparations and early-season prospects.

The gravity of the situation became apparent in September, prior to the team’s training camp in Hawaii, when the Warriors formally announced Porziņģis’ indefinite absence. At the time, General Manager Mike Dunleavy attempted to temper concerns, stating, "I’m not marking him down as being out to start the season or anything like that. He’s just not available this week. … Disappointed that he won’t be out there tomorrow, but it’s early, so don’t want to overreact to anything." However, as the calendar has flipped deeper into October and the preseason schedule has progressed, Dunleavy’s initial optimism has given way to a more palpable sense of unease within the organization and among the fanbase.

Porziņģis has been a non-participant throughout training camp and has missed all four of the team’s preseason contests thus far. Head coach Steve Kerr, a figure typically known for his measured optimism, offered little in the way of a concrete update when addressing reporters on October 8th. "He is not here today. We’ve obviously been busy in Hawaii and Portland, so we just came in and worked out the vets, had a really good practice. I’ll reach out to KP today and check in with him, but nothing new to report," Kerr explained, adding only that he had exchanged texts with Porziņģis, who seemed to be "doing OK." This vague update has done little to assuage the growing concerns about the timeline for his return, particularly given the critical role he is expected to play for the veteran-laden squad.

The Warriors’ decision to re-sign Porziņģis this summer, despite his well-documented history of health issues, was a calculated gamble. The team acquired him at the trade deadline last season in a blockbuster deal that sent promising young forward Jonathan Kuminga and sharpshooter Buddy Hield to the Atlanta Hawks. In his 15 games with the Warriors following that trade, Porziņģis showcased glimpses of his unique talent, averaging 16.1 points, 5.3 rebounds, 2.3 assists, and 1.1 blocks. However, his shooting percentages — 43.3% from the field and a less-than-ideal 31.1% from 3-point range — reflected a player still integrating into a new system, and perhaps, not yet at full health. The potential impact of his 7-foot-3 frame, ability to stretch the floor, and rim protection offered a tantalizing vision for a Warriors team seeking to extend its championship window with an aging core of Steph Curry and Draymond Green, now joined by the equally veteran presence of Jimmy Butler.

Porziņģis, the former No. 4 overall pick in the 2015 NBA Draft, entered the league with immense hype, earning the moniker "The Unicorn" for his unprecedented combination of size, shooting touch, and defensive versatility. His early career with the New York Knicks was marked by flashes of brilliance, but also by a recurring pattern of injuries that have consistently derailed his momentum. A torn ACL in 2018 cost him the entire 2018-19 season, a devastating blow that set the tone for much of his subsequent career. Beyond the ACL, Porziņģis has battled a litany of ailments, including meniscus tears, ankle sprains, foot issues, and various soft tissue injuries, which have severely limited his availability. In his 10 seasons in the NBA, he has only managed to surpass the 65-game mark on three occasions, and in the three seasons preceding his current Warriors stint (with the Boston Celtics, Atlanta Hawks, and Warriors, respectively), he played just 57, 42, and 32 games. This consistent struggle to stay on the court underscores the inherent risk the Warriors assumed in committing significant cap space to him.

Adding another layer of complexity to his current situation is his previous diagnosis of postural orthostatic tachycardia syndrome (POTS). Near the end of his final season in Boston in 2025, Porziņģis began experiencing extreme fatigue, which ultimately led to the POTS diagnosis. This condition is characterized by an abnormal increase in heart rate that occurs when a person stands up, often leading to symptoms such as dizziness, lightheadedness, and profound exhaustion. "You know how people say, ‘Oh, I’m so fatigued.’ I’ve never used those words. I don’t even like to speak in those terms, but I really was like that," Porziņģis openly shared ahead of last season. "At that time, I could just lay on the couch and be a house cat." Neither the Warriors organization nor Porziņģis, who has not engaged with the media since April, has offered any insight into whether his current "mysterious illness" is related to his previously diagnosed POTS. The lack of transparency only fuels speculation and heightens anxiety regarding the severity and potential duration of his absence.

The Warriors’ injury woes extend far beyond Porziņģis, compounding the challenges facing the team as the 2026-27 season draws near. The table below illustrates the dire situation, highlighting three notable and well-paid players currently sidelined:

With Butler, Porziņģis, and Moses Moody (out with a torn patellar tendon) all sidelined, the Warriors are currently carrying approximately $90 million worth of contracts tied up in injured players. This staggering financial burden, coupled with the absence of key contributors, presents a significant roster challenge for a team operating deep in the luxury tax. Dunleavy’s candid admission in August regarding the team’s strategic choices rings particularly true now: "I think in constructing (the roster), we had to make a decision between talent and availability. There was no perfect solution in terms of a combination of the two, and I think we leaned a little bit more towards talent, knowing the team that we have, what we need. And (we) hope that we can get some good luck, but also improve in some areas medically." So far, the "good luck" has been conspicuously absent, and the "improvement in some areas medically" has yet to materialize for Porziņģis.

The timing of these injuries is especially problematic for a team with championship aspirations and an aging core. While Steph Curry continues to defy Father Time, and Draymond Green remains an elite defensive anchor, the team’s depth and overall talent level are being severely tested. The preseason is a crucial period for integrating new players, refining offensive and defensive schemes, and building chemistry. Porziņģis’ absence has undoubtedly disrupted this process, forcing Coach Kerr to experiment with different lineups and rely more heavily on players like Kevon Looney and other younger or less experienced big men to fill the void. The "next man up" mentality, a staple of Kerr’s coaching philosophy, is being tested perhaps more rigorously than ever before.

"Circumstances change every year. You get thrown a lot of curveballs in this business. It’s always the same mentality — next man up, prepare for what’s in front of you and support everybody who’s not here," Kerr reiterated on October 8th, reflecting the stoic resolve of a veteran coach. "Whether it’s Jimmy or KP or Moses, we’re always gonna give our players every bit of support and help them be the best versions of themselves and acknowledge that the train doesn’t stop moving. We’re having a great camp, really pleased with the progress we’re making. Obviously, we’d rather have KP here and part of it, but he’s gotta take care of his health and we’ll support that and keep moving forward with the team."

As the regular season opener against the Lakers looms, the Golden State Warriors find themselves at a critical juncture. The gamble on Porziņģis’ talent over his availability has, at least in the short term, not paid off. The team’s ability to navigate these significant injury challenges, especially with a pivotal big man and a newly acquired star like Butler sidelined, will define their early season trajectory. The hope remains that Porziņģis can make a full recovery and eventually contribute to the team’s pursuit of another championship, but for now, the Warriors are left to confront a future that is as uncertain as the nature of his current illness.